CID HoldCo, Inc. (DAICW) Stock Price & Analysis
CID HoldCo, Inc. (DAICW) closed at USD 0.01 on Thursday, October 15, 2026, up 55.38% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.01; the Oct 15, 2026 session ranged USD 0.01–0.02 on volume of 76,100 shares. Market capitalization is —, with a 52-week range of USD 0.01–0.02 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DAICW.md
Key facts (DAICW)
- Analysts: None.
Analysts (DAICW)
Consensus None.
Key Statistics (as of October 16, 2026 at 05:11 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 55.38% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.01 |
| Day Range | USD 0.01 – 0.02 |
| 52-Week Range | USD 0.01 – 0.02 |
| Volume | 76,100 shares |
| Market Cap | — |
| Exchange | NGM |
Analyst Ratings (DAICW)
Wall Street analysts rate DAICW "None", per Nexqual as of October 16, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (DAICW)
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financials & Fundamentals (DAICW)
| Total Revenue | $5.35M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -90.20% |
| Gross Margin | +42.83% |
| Operating Margin | -24437.24% |
| Profit Margin | -276.85% |
| Current Ratio | 0.27 |
| Total Cash | $456,069 |
| Total Debt | $2.35M |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Financial Health Score (DAICW)
Nexqual rates CID HoldCo, Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:11 UTC.
| Growth | Critical — Revenue -90% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $456K cash vs $2M debt |
| Cash Flow | Weak — Operating cash flow -$9M (TTM) |
| Efficiency | Mixed — No data |
Ownership (DAICW)
| Float | 2.02M |
|---|
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Major Backers & Investors (DAICW)
Notable institutional backers of CID HoldCo, Inc. include Calamos Advisors LLC, CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund, Aristeia Capital, LLC, according to Nexqual as of October 16, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Calamos Advisors LLC | 6.38% |
| CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund | 6.38% |
| Aristeia Capital, LLC | 6.1% |
| Saba Capital Management, L.P. | 5.24% |
| Clear Street Group Inc. | 3.84% |
| Blue Owl Capital Holdings LP | 2.84% |
| Warberg Asset Management LLC | 2.41% |
| Sculptor Capital LP | 2.07% |
Source: Nexqual, October 16, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| DAIC | CID HoldCo, Inc. | USD 1.31 | ▼ 18.63% |
| LIMNW | Liminatus Pharma, Inc. Warrants | USD 0.04 | ▼ 8.05% |
| KIDZW | Classover Holdings, Inc. Warran | USD 0.01 | ▲ 1.27% |
| BZAIW | Blaize Holdings, Inc. Warrants | USD 0.02 | ▼ 2.79% |
| ENGNW | enGene Holdings Inc. Warrants | USD 0.17 | ▲ 5.07% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt